Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer

European Journal of Cancer

Volumn 33, Issue 13, 1997, Pages 2216-2220

  Painbeni, T ^a   Gamelin, E ^b   Cailleux, A ^a   Le Bouil, A ^a   Boisdron Celle, M ^b   Daver, A ^b   Larra, F ^b   Allain, P ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Centre Anti Cancéreux Paul Papin   (France)

Author keywords

Carbohydrate antigen 19 9; Carcinoembryonic antigen; Metastatic colorectal carcinoma; Total sialic acid; Tumour marker

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; SIALIC ACID; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, NEOPLASM; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0031418278     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00318-3     Document Type: Article

References (30)

1. Alvarez JA, Marin J, Jover JM, Fernandez R, Fradejas J, Moreno M. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 19-9 in the diagnostic of colorectal adenocarcinoma. Dis Colon Rectum 1995, 38, 535-542.
2. McKendrick JJ, Xing PX, McKenzie IFC. Tumour markers in colon cancer. Diagnose Oncol 1994, 4, 2-3.
3. Safi F, Bittner R, Roscher R, Kubel R, Beger HG. The value of CA 19-9 in gastric and colorectal carcinoma. Cancer Invest 1987, 5, 401-407.
4. Erbil KM, Jones JD, Klee GG. Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer. Cancer 1985, 55, 404-409.
5. Verazin G, Riley WM, Gregory J, Tautu C, Prorok JJ, Alhadeff JA. Serum acid sialic and carcinoembryonic levels in the detection and monitoring of colorectal cancer. Dis Colon Rectum 1990, 33, 139-142.
6. Kakari S, Stringou E, Toumbis M. Five tumor markers in lung cancer: significance of total and lipid-bound sialic acid. Anticancer Res 1991, 11, 2107-2110.
7. Gamelin E, Dorval E, Dumesnil Y, et al. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving 5FU containing infusional therapy. Cancer 1996, 77, 441-451.
8. Dnistrian AM, Schwanz MK. Plasma Lipid-bound sialic acid and carcinoembryonic antigen in cancer patients. Clin Chem 1981, 27, 1737-1739.
9. Moertel CG, Fleming TR, Me Donald JS, Haller DG, Laurie JA, Goodman PJ. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N EnglJMed 1990, 322, 352-358.
10. Machover D, Goldschmidt E, Chollet P. Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high dose folinic acid. J Clin Oncol 1986, 4, 685-696.
11. Stringou E, Chondros K, Kouvaris J, Kakaris S, Papavassiliou K. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy. Anticancer Res 1992, 12, 251-256.
12. Friedman J, Levinsky H, Allalouf D, Staroselsky A. Sialic acid content in mouse myeloma cells and derived B-cell hybridomas with diiferent metastatic potentials. Cancer Lett 1988, 43, 79-84.
13. Jaques LW, Brown EB, Barren JM, Brey WS, Weltner W Jr. Sialic acid: a calcium binding carbohydrate. J Biol Chem 1977, 252, 4533-4538.
14. Raz A, Bucana C, McLellan W, Fidler IJ. Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential. Nature 1980, 284, 363-364.
15. Yogeeswaran G, Salk PL. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 1981, 212, 1514-1516.
16. Morgenthaler J, Kemmer W, Brossmer R. Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT166b. Biochem Biophys Res Commun 1990, 171, 860-866.
17. Narayanan S. Sialic acid as a tumor marker. Ann Clin Lab Sci 1994, 24, 376-384.
18. Berge PG, Wilhelm A, Schriewer H, Wüst G. Serum-sialyltranferase activity in cancer patients. Klin Wochenschr 1982, 60, 445-4149.
19. Plucinsky MC, Riley WM, Prorok JJ, Alhadeff JA. Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer 1986, 58, 2680-2685.
20. Lindmark G, Bergstrom R, Pahlman L, Glimelius B. The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. Br J Cancer 1995, 71, 1090-1094.
21. Silver HKB, Karim KA, Salinas FA, Swenerton KD. Significance of sialic acid and carcinoembryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary. Surg Gynecol Obstet 1981, 153, 209-213.
22. Patel PS, Adhvaryu SG, Balar DB, Parikh BJ, Shah PM. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias. Anticancer Res 1994, 14, 747-752.
23. Marth E, Flaschka G, Stiegler S, Möse JR. Sialic acid as a marker for differentiation between benign and malignant intracranial tumors. Clin Chim Acta 1988, 176, 251-258.
24. Kökoglu E, Sönmez H, Uslu E, Uslu I. Sialic acid levels in various types of cancer. Cancer Biochem Biophys 1992, 13, 57-64.
25. Shamberger RJ. Serum sialic acid in normals and in cancer patients. J Clin Chem Clin Biochem 1984, 22, 647-651.
26. Lindberg G, Rastam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson BS. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993, 103, 123-129.
27. Allain P, Olivier E, Le Bouil A, Benoit C, Geslin P, Tadei A. Augmentation de la concentration d'acide sialique dans le plasma de malades atteints de coronaropathies. Presse Med 1996, 25, 96-98.
28. Stefenelli N, Klotz H, Engel A, Bauer P. Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. J Cancer Res Clin Oncol 1985, 109, 55-59.
29. Carpellanholmstrom M, Haglund C, Kuusela P, Jarvinen H, Roberts PJ. Preoperative serum levels of CEA and CA 242 in colorectal cancer. BrJ Cancer 1995, 71, 868-872.
30. Kornek G, Depisch D, Temsch EM, Scheithauer W. Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response of chemotherapy in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 1991, 117, 493-496.